Biochemical study demonstrates lipopolysaccharide triggers early bone resorption in cholesteatoma, suggesting targeted anti-inflammatory therapies could preserve hearing.
It is suggested that LPS is one of the first factors in the cascade of bone resorption in COM with cholesteatoma.
No takes yet. Share an insight, caveat, or question.
Peek et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: